Hillside Certified Home Care Agency | |
3155 Grace Avenue, Bronx, New York 10469 | |
(718) 291-3500 | |
Not Available |
Name | Hillside Certified Home Care Agency |
---|---|
Location | 3155 Grace Avenue, Bronx, New York |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 337262 |
Ownership Type | Proprietary |
Service Area Zip Codes | 11214, 11224, 11229, 11235 |
NPI Number | 1013090166 |
Organization Name | HILLSIDE MANOR REHABILITATION AND EXTENDED CARE CENTER, LLC |
Doing Business As | HILLSIDE MANOR LONG TERM HOME HEALTH CARE PROGRAM |
Address | 18811 Hillside Ave, Hollis, NY 11423 |
Phone Number | 718-291-3500 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of new clinical data with the Company's targeted anticancer compound, IMGN901.
Patients with very-late-onset schizophrenia-like psychosis have an increased risk of death compared with both the general population and patients with schizophrenia diagnosed earlier in life, Finnish study findings indicate.
Techulon Inc., a life sciences company, has signed worldwide exclusive license agreements with the University of Cincinnati to manufacture and sell novel transfection reagents used for research and therapeutic delivery of nucleic acids.
The Los Angeles Times: "The Obama administration is sending $1-million grants to state insurance regulators to help increase oversight of rising health insurance premiums, a key step in implementing the new healthcare law. The grants announced Monday, which went to all but five states, will enable many to expand public access to information about rate hikes and to hire experts to review what insurers want to charge.
› Verified 7 days ago
NPI Number | 1104337542 |
Organization Name | JAMAICA ACQUISITION III LLC |
Doing Business As | HILLSIDE CERTIFIED HOME HEALTH CARE AGENCY |
Address | 3155 Grace Ave, Bronx, NY 10469 |
Phone Number | 718-291-3500 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of new clinical data with the Company's targeted anticancer compound, IMGN901.
Patients with very-late-onset schizophrenia-like psychosis have an increased risk of death compared with both the general population and patients with schizophrenia diagnosed earlier in life, Finnish study findings indicate.
Techulon Inc., a life sciences company, has signed worldwide exclusive license agreements with the University of Cincinnati to manufacture and sell novel transfection reagents used for research and therapeutic delivery of nucleic acids.
The Los Angeles Times: "The Obama administration is sending $1-million grants to state insurance regulators to help increase oversight of rising health insurance premiums, a key step in implementing the new healthcare law. The grants announced Monday, which went to all but five states, will enable many to expand public access to information about rate hikes and to hire experts to review what insurers want to charge.
› Verified 7 days ago
NPI Number | 1285858175 |
Organization Name | LYNN AGENCY, INC. |
Address | 8002 Kew Gardens Rd, Suite 1050, Kew Gardens, NY 11415 |
Phone Number | 718-261-6400 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of new clinical data with the Company's targeted anticancer compound, IMGN901.
Patients with very-late-onset schizophrenia-like psychosis have an increased risk of death compared with both the general population and patients with schizophrenia diagnosed earlier in life, Finnish study findings indicate.
Techulon Inc., a life sciences company, has signed worldwide exclusive license agreements with the University of Cincinnati to manufacture and sell novel transfection reagents used for research and therapeutic delivery of nucleic acids.
The Los Angeles Times: "The Obama administration is sending $1-million grants to state insurance regulators to help increase oversight of rising health insurance premiums, a key step in implementing the new healthcare law. The grants announced Monday, which went to all but five states, will enable many to expand public access to information about rate hikes and to hire experts to review what insurers want to charge.
› Verified 7 days ago
NPI Number | 1649664665 |
Organization Name | MORNINGSIDE ACQUISITION I LLC |
Address | 3155 Grace Ave, Bronx, NY 10469 |
Phone Number | 718-304-2866 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of new clinical data with the Company's targeted anticancer compound, IMGN901.
Patients with very-late-onset schizophrenia-like psychosis have an increased risk of death compared with both the general population and patients with schizophrenia diagnosed earlier in life, Finnish study findings indicate.
Techulon Inc., a life sciences company, has signed worldwide exclusive license agreements with the University of Cincinnati to manufacture and sell novel transfection reagents used for research and therapeutic delivery of nucleic acids.
The Los Angeles Times: "The Obama administration is sending $1-million grants to state insurance regulators to help increase oversight of rising health insurance premiums, a key step in implementing the new healthcare law. The grants announced Monday, which went to all but five states, will enable many to expand public access to information about rate hikes and to hire experts to review what insurers want to charge.
› Verified 7 days ago
NPI Number | 1790186443 |
Organization Name | HILLSIDE MANOR REHABILITATION AND EXTENDED CARE CENTER, LLC |
Doing Business As | HILLSIDE MANOR CERTIFIED HOME HEALTH AGENCY |
Address | 18811 Hillside Ave, Hollis, NY 11423 |
Phone Number | 718-291-3500 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of new clinical data with the Company's targeted anticancer compound, IMGN901.
Patients with very-late-onset schizophrenia-like psychosis have an increased risk of death compared with both the general population and patients with schizophrenia diagnosed earlier in life, Finnish study findings indicate.
Techulon Inc., a life sciences company, has signed worldwide exclusive license agreements with the University of Cincinnati to manufacture and sell novel transfection reagents used for research and therapeutic delivery of nucleic acids.
The Los Angeles Times: "The Obama administration is sending $1-million grants to state insurance regulators to help increase oversight of rising health insurance premiums, a key step in implementing the new healthcare law. The grants announced Monday, which went to all but five states, will enable many to expand public access to information about rate hikes and to hire experts to review what insurers want to charge.
› Verified 7 days ago
NPI Number | 1861938425 |
Organization Name | LYNN AGENCY INC CDPAP |
Address | 18811 Hillside Ave, Hollis, NY 11423 |
Phone Number | 718-261-6400 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of new clinical data with the Company's targeted anticancer compound, IMGN901.
Patients with very-late-onset schizophrenia-like psychosis have an increased risk of death compared with both the general population and patients with schizophrenia diagnosed earlier in life, Finnish study findings indicate.
Techulon Inc., a life sciences company, has signed worldwide exclusive license agreements with the University of Cincinnati to manufacture and sell novel transfection reagents used for research and therapeutic delivery of nucleic acids.
The Los Angeles Times: "The Obama administration is sending $1-million grants to state insurance regulators to help increase oversight of rising health insurance premiums, a key step in implementing the new healthcare law. The grants announced Monday, which went to all but five states, will enable many to expand public access to information about rate hikes and to hire experts to review what insurers want to charge.
› Verified 7 days ago
Quality Rating: | Not Available* |
* The number of patient episodes for this measure is too small to report. |
News Archive
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of new clinical data with the Company's targeted anticancer compound, IMGN901.
Patients with very-late-onset schizophrenia-like psychosis have an increased risk of death compared with both the general population and patients with schizophrenia diagnosed earlier in life, Finnish study findings indicate.
Techulon Inc., a life sciences company, has signed worldwide exclusive license agreements with the University of Cincinnati to manufacture and sell novel transfection reagents used for research and therapeutic delivery of nucleic acids.
The Los Angeles Times: "The Obama administration is sending $1-million grants to state insurance regulators to help increase oversight of rising health insurance premiums, a key step in implementing the new healthcare law. The grants announced Monday, which went to all but five states, will enable many to expand public access to information about rate hikes and to hire experts to review what insurers want to charge.
› Verified 7 days ago
News Archive
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of new clinical data with the Company's targeted anticancer compound, IMGN901.
Patients with very-late-onset schizophrenia-like psychosis have an increased risk of death compared with both the general population and patients with schizophrenia diagnosed earlier in life, Finnish study findings indicate.
Techulon Inc., a life sciences company, has signed worldwide exclusive license agreements with the University of Cincinnati to manufacture and sell novel transfection reagents used for research and therapeutic delivery of nucleic acids.
The Los Angeles Times: "The Obama administration is sending $1-million grants to state insurance regulators to help increase oversight of rising health insurance premiums, a key step in implementing the new healthcare law. The grants announced Monday, which went to all but five states, will enable many to expand public access to information about rate hikes and to hire experts to review what insurers want to charge.
› Verified 7 days ago
Montefiore Med Ctr Home Care Chha Location: One Fordham Plaza Suite 1100, Bronx, New York 10458 Ratings: Phone: (718) 405-4400 | |
Calvary Hospital Chha Location: 1740 Eastchester Road, Bronx, New York 10461 Ratings: NA Phone: (718) 430-9540 | |
Hillside Certified Home Care Agency Location: 3155 Grace Avenue, Bronx, New York 10469 Ratings: NA Phone: (718) 291-3500 | |
Briah Home Care Location: 3525 Baychester Avenue, Bronx, New York 10466 Ratings: NA Phone: (718) 298-3900 | |
Rebekah Certified Home Health Agency Location: 1040 Havemeyer Avenue, Bronx, New York 10462 Ratings: Phone: (718) 863-6200 | |
Atara Home Care Location: 3525 Baychester Avenue, Bronx, New York 10466 Ratings: Phone: (212) 235-5100 |